Where can researchers source third-party tested MOTS-c?

Midwest Peptide supplies research-grade MOTS-c with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Memorial Day: 15% off code MEMDAY15Memorial Day Sale — 15% off site-wide with code MEMDAY15

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

MOTS-c Aging Research: Longevity Studies | Midwest Peptide

Glutathione in Research: A Master Antioxidant Literature ReviewPrev|MOTS-c Exercise Research: Published Animal Model StudiesNext

MOTS-c Aging Research: Longevity Endpoint Studies in Animal Models

MOTS-c · Published April 9, 2026 · Updated May 18, 2026 · 9 min read

Quick Answer

MOTS-c aging research examines age-associated declines, metabolic aging biology, exercise capacity, and mitochondrial aging in rodent models. Studies measure MOTS-c expression patterns, AMPK activation, and longevity endpoints across standardized aging research protocols using this mitochondrial-derived peptide. For research use only, not for human consumption.

MOTS-c Aging Research: Longevity Endpoint Studies in Animal Models

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

MOTS-c Levels Across the Lifespan
MOTS-c Administration in Aging Research Models
Metabolic Aging in Research Models
Exercise Capacity in Aged Research Animals
Mitochondrial Aging and MOTS-c
Body Composition Changes With Age
MOTS-c Compared to Other Aging Research Tools
Compliance Note
Open Research Questions
Conclusion
Related Research Articles
Explore Related Products
Frequently Asked Questions
Glossary

MOTS-c aging research has produced one of the more discussed areas of preclinical literature on mitochondrial-derived peptides and biological aging. Multiple animal model studies have characterized how MOTS-c levels change with age and how MOTS-c administration affects various aging-related endpoints in research animals. As the aging research component of the MOTS-c research cluster, this article reviews the published animal model literature on MOTS-c and aging in research models.

Frequently Asked Questions

What is MOTS-c in research contexts?

MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA region of mitochondrial DNA. It is studied in preclinical research as an exercise mimetic, an AMPK activator, and a regulator of metabolic homeostasis and aging biology.

How is MOTS-c studied in aging research?

MOTS-c levels decline with age in rodents and humans. Research models examine whether MOTS-c administration can restore age-associated metabolic decline, exercise capacity, and lifespan endpoints, with published rodent studies reporting modest lifespan extension.

What aging endpoints are measured in MOTS-c research?

Endpoints include exercise capacity, metabolic flexibility, body composition, frailty markers, mitochondrial function in muscle and other tissues, and integrated longevity outcomes including median and maximal lifespan in cohort studies.

Is MOTS-c approved for human use?

No. MOTS-c is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Glossary

Key terms used in this article.

Mitochondrial-Derived Peptide (MDP): A class of small bioactive peptides encoded within the mitochondrial genome and translated within or near mitochondria.
AMPK: AMP-activated protein kinase, a cellular energy sensor activated under low ATP conditions to restore metabolic homeostasis.
Exercise Mimetic: A compound that produces molecular and physiological adaptations associated with physical exercise without requiring activity.
Mitochondrial Biogenesis: The cellular process of generating new mitochondria, regulated by PGC-1 alpha and other transcriptional coactivators.
Healthspan: The period of life lived in good health, distinct from total lifespan, and a key endpoint in aging research.
Frailty: An age-associated state of decreased physiological reserve and increased vulnerability to stressors.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

For Research Use Only. This article discusses preclinical animal model research exclusively. MOTS-c is intended only for in vitro and laboratory research, is not approved for human use, is not a drug or anti-aging product, and is not associated with any human aging or longevity claims.

MOTS-c Levels Across the Lifespan

One of the foundational observations in MOTS-c aging research is the change in MOTS-c levels across the lifespan in research animals. Studies have characterized MOTS-c levels in plasma and tissues at various ages in rodent and other research models, with the published findings generally supporting age-associated declines in MOTS-c levels.

The pattern of declining MOTS-c levels with age is similar to age-associated declines observed for other molecules studied in aging research, including the GHK plasma decline that motivated GHK-Cu research and the NAD+ decline that motivated NAD+ longevity research. The convergence across multiple molecules suggests that the broader cellular biology of aging involves declining levels of multiple regulatory molecules, with MOTS-c being one specific example.

The age-associated decline in MOTS-c levels has motivated research on whether restoring MOTS-c levels through supplementation can reverse age-associated phenotypes in research animals. This restoration approach is similar to the approach used in NAD+ research and has been the basis for substantial preclinical research on MOTS-c and aging endpoints.

For comparison with the related NAD+ aging research, see our NAD+ longevity studies article.

MOTS-c Administration in Aging Research Models

Animal model studies of MOTS-c administration in aging research have used various approaches to characterize how the peptide affects aging-related endpoints. Standard approaches include short-term studies in young versus old research animals to characterize age-dependent effects, longer-term studies that follow research animals through aging while administering MOTS-c, and various combinations that probe different aspects of aging biology.

The published findings on MOTS-c administration in aging research models support effects on multiple aging-related endpoints. These include effects on metabolic parameters (consistent with the broader AMPK pathway effects discussed in our companion article on MOTS-c metabolic homeostasis and AMPK research), effects on exercise capacity in aged research animals, effects on body composition, and various other endpoints relevant to aging biology.

The mechanism by which MOTS-c affects aging-related endpoints in research models involves the AMPK pathway activation and downstream metabolic effects. The connection between cellular energy sensing and aging biology is one of the more studied topics in aging research, and MOTS-c provides one specific example of how mitochondrial-derived signaling can affect age-related metabolic changes.

Metabolic Aging in Research Models

Metabolic changes are one of the major characteristics of aging in research animals. These changes include declining glucose handling, reduced insulin sensitivity, declining mitochondrial function, increased adiposity, and various other metabolic features that change with age in research models.

MOTS-c effects on these metabolic aging features have been characterized in research models, with the published findings generally supporting beneficial effects on age-associated metabolic changes. The improvements include enhanced glucose handling in aged research animals, improved insulin sensitivity, and various other metabolic improvements consistent with the AMPK pathway mechanism.

The connection between MOTS-c and metabolic aging is one of the more practical aspects of MOTS-c aging research because metabolic endpoints are well characterized and reproducible in research models. The use of MOTS-c as a research tool for studying metabolic aging provides a specific molecular intervention that can be combined with other aging research approaches.

Exercise Capacity in Aged Research Animals

Exercise capacity is another major endpoint in aging research because it integrates multiple physiological systems and reflects the broader functional status of research animals. Aging is generally associated with declining exercise capacity in research animals, providing a context for studying interventions that might affect this aging-related decline.

MOTS-c effects on exercise capacity in aged research animals have been characterized in published research, with findings that generally support improvements in exercise performance with peptide administration. The improvements are consistent with the broader exercise mimetic research on MOTS-c and reflect the AMPK pathway activation and downstream metabolic effects characterized in younger research animals as well.

For more on the exercise effects of MOTS-c, see our companion article on MOTS-c exercise research and animal model studies.

The connection between MOTS-c, exercise mimetic effects, and aging biology is one of the more conceptually interesting aspects of MOTS-c research. The peptide may provide a research tool for studying how exercise-related signaling pathways contribute to healthy aging in research models.

Mitochondrial Aging and MOTS-c

Mitochondrial dysfunction is one of the proposed mechanisms of biological aging, and the connection between MOTS-c (a mitochondrial-derived peptide) and aging biology has natural conceptual appeal. The hypothesis is that mitochondrial-derived signaling contributes to integrated cellular function in ways that may decline with age, and that restoring this signaling through MOTS-c administration may affect aging-related phenotypes.

The published research on mitochondrial aging and MOTS-c has characterized effects on mitochondrial function in aged research animals, including measurements of mitochondrial respiration, mitochondrial biogenesis markers, and various other endpoints relevant to mitochondrial biology. The findings generally support improvements in mitochondrial function with MOTS-c administration in research models.

The connection between MOTS-c and mitochondrial aging integrates with broader research on mitochondrial dysfunction as a feature of aging. Multiple research lines have characterized declining mitochondrial function with age in research models, and the use of mitochondrial-targeted interventions like MOTS-c provides one approach to studying whether restoring mitochondrial function can affect age-related phenotypes.

Body Composition Changes With Age

Body composition typically changes with age in research animals, including increased fat mass and changes in lean tissue mass. These changes contribute to the broader phenotype of biological aging and provide measurable endpoints for studying interventions that might affect age-related body composition changes.

MOTS-c effects on body composition in aged research animals have been characterized in published research, with findings that include effects on fat mass, lean mass, and various other endpoints relevant to body composition aging. The improvements are consistent with the broader metabolic effects of MOTS-c and connect the aging research to the broader metabolic literature on the peptide.

The body composition effects of MOTS-c in aged research animals are one of the more measurable endpoints in aging research and provide functional validation of the molecular and metabolic effects characterized in other research contexts.

MOTS-c Compared to Other Aging Research Tools

MOTS-c is one of several research compounds that have been studied as potential interventions for age-related changes in research models. Other examples include NAD+ precursors (NR, NMN), sirtuin pathway compounds, AMPK activators (such as the small molecule AICAR), and various other research tools.

The comparison between MOTS-c and other aging research compounds provides context for understanding the specific characteristics of the peptide. MOTS-c is a peptide rather than a small molecule, which gives it different pharmacological properties than the small molecule activators. The peptide nature also makes it functionally similar to natural endogenous mitochondrial-derived signaling.

The use of MOTS-c as an aging research tool complements rather than replaces other aging research approaches. Each tool has its own strengths and appropriate research applications, and the combined use of multiple aging research compounds in comparative research designs can provide more comprehensive characterization of aging biology.

Compliance Note

This article discusses preclinical animal model research exclusively. The findings reviewed above are from controlled studies in research animals and do not constitute claims about human aging, human longevity, or human health. MOTS-c supplied by Midwest Peptide is for in vitro and preclinical research only and is not intended for any human application. Investigators interested in the published literature on MOTS-c and aging should consult the peer reviewed research directly when planning research projects.

Open Research Questions

Several open research questions remain in the MOTS-c aging research literature. These include how the age-associated decline in MOTS-c levels integrates with other aging-related changes in research animals, how MOTS-c administration affects long-term aging endpoints in standardized research animal models, and how MOTS-c interacts with other aging research interventions in combined research designs. Each of these is a legitimate research opportunity for investigators studying aging biology.

Conclusion

MOTS-c aging research provides one of the more discussed areas of preclinical literature on mitochondrial-derived peptides and biological aging in research models. The convergent findings on age-associated MOTS-c declines, beneficial effects on metabolic aging, exercise capacity improvements in aged research animals, and effects on mitochondrial function support the use of MOTS-c as a research tool for studies of aging biology. For investigators using MOTS-C 10mg as a research tool, the aging literature provides essential context for experimental design within the strict preclinical framing required for this research area.

For more on the full MOTS-c research cluster, see the pillar overview article and the supporting articles on each major topic.

MOTS-c is supplied by Midwest Peptide for research use only and is not intended for human administration.

Explore more peer-reviewed research and laboratory guides from our science team:

All products are third-party tested with a Certificate of Analysis (COA) included. For research use only.

MOTS-C 10mg, 99%+ purity, COA included
NAD+ 500mg, 99%+ purity, COA included
Glutathione 1500mg, 99%+ purity, COA included
GHK-Cu 50mg, 99%+ purity, COA included

Browse All Research Peptides →

Age Verification

MOTS-c Aging Research: Longevity Endpoint Studies in Animal Models